Monday, April 27, 2015
Medtronic agrees to FDA consent decree on drug pump
(Reuters) - Medtronic Plc has agreed to resolve U.S. regulators' allegations it violated quality standards for making its SynchroMed implantable infusion pump, which delivers medications to cancer patients and others with chronic pain.Medtronic agrees to FDA consent decree on drug pump
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.